Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Glioma × Neoadjuvant Therapy × Clear all

Phase

Status

Completed 3 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 10 Esophageal Neoplasms 5 Colorectal Neoplasms 5 Rectal Neoplasms 4 Esophageal Squamous Cell Carcinoma 4 Carcinoma, Non-Small-Cell Lung 4 Adenocarcinoma Of Esophagus 4 Sarcoma 3 Lung Neoplasms 3 Uterine Cervical Neoplasms 2 Pancreatic Neoplasms 2 Osteosarcoma 2 Neoplasms 2 Melanoma 2 Vomiting 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Sarcoma, Alveolar Soft Part 1 Rhabdomyosarcoma 1 Prostatic Neoplasms 1 Peritoneal Metastases From Gastric Cancer 1 Peritoneal Metastases From Colorectal Cancer 1 Neurofibrosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasms, Squamous Cell 1 Neoplasm Metastasis 1 Nausea 1 Multiple Myeloma 1 Malignant mesenchymal tumor 1

Interventions

Temozolomide 22 Bevacizumab 10 Radiotherapy 5 Magnetic Resonance Spectroscopy 5 Irinotecan 5 Carmustine 4 fluorodopa F 18 3 Topotecan 3 Surgical Procedures, Operative 3 Standard of Care 3 Radiosurgery 3 Magnetic Resonance Imaging 3 Congresses as Topic 3 Carboplatin 3 Aminolevulinic Acid 3 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 3 ribociclib 2 poly ICLC 2 fluoromisonidazole 2 carmustine, poliferprosan 20 drug combination 2 cabozantinib 2 Vorinostat 2 TIC10 compound 2 Re-Irradiation 2 Radiotherapy, Intensity-Modulated 2 Panobinostat 2 O(6)-benzylguanine 2 Melphalan 2 Lomustine 2 Lacosamide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04209790 2025-11-10

NeoGlio

Geisinger Clinic

Phase 2 Terminated

2 enrolled 7 charts

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡